Lv21
130 积分 2022-10-10 加入
Risk Factors for The Growth of Residual Nodule in Surgical Patients with Adenocarcinoma Presenting as Multifocal Ground-glass Nodules
7分钟前
待确认
Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions
1小时前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
1小时前
已完结
Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: Their natural course and predictors of interval growth
1小时前
已完结
Natural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low-Dose CT Scan
2小时前
已完结
Breast cancer
5小时前
已完结
Metaplastic breast cancer: A review
6小时前
已完结
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor–Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2–Low or Human Epidermal Growth Factor Receptor 2–Ultralow Breast Cancer
19天前
已关闭
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
19天前
已完结
Dual-payload ADCs move into first oncology clinical trials
1个月前
已完结
皖公网安备34019202002308
